ttx-mc138
·Code: TTX-MC138
ttx-mc138: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | Phase 1/Phase 2 |
Clinical Trials (1)
A Phase 1/2 Multicenter, Open-Label, Dose-escalation and Expansion Study of TTX-MC138 in Subjects With Advanced Solid Tumors
Frequently asked questions
Who is developing ttx-mc138?
ttx-mc138 is being developed by Transcode Therapeutics, Inc..
How many clinical trials involve ttx-mc138?
BioSniper tracks 1 clinical trial involving ttx-mc138.
Get deeper analysis on ttx-mc138
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis